Chlorine in PDB 6vfv: Crystal Structure of Human Protocadherin 8 EC5-EC6

The structure of Crystal Structure of Human Protocadherin 8 EC5-EC6, PDB code: 6vfv was solved by O.J.Harrison, J.Brasch, L.Shapiro, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	19.90 / 2.90
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	41.658, 29.498, 92.442, 90.00, 98.46, 90.00
R / Rfree (%)	22.5 / 26.4

The structure of Crystal Structure of Human Protocadherin 8 EC5-EC6 also contains other interesting chemical elements:

Calcium

(Ca)

4 atoms

The binding sites of Chlorine atom in the Crystal Structure of Human Protocadherin 8 EC5-EC6 (pdb code 6vfv). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Human Protocadherin 8 EC5-EC6, PDB code: 6vfv:

Chlorine binding site 1 out of 1 in the Crystal Structure of Human Protocadherin 8 EC5-EC6


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human Protocadherin 8 EC5-EC6 within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl712 b:56.6 occ:1.00 HA2 A:GLY484 3.5 30.0 1.0 HA3 A:GLY484 3.6 30.0 1.0 HD22 A:LEU535 3.6 37.8 1.0 HA A:LEU535 3.7 37.7 1.0 CA A:GLY484 3.9 25.0 1.0 N A:GLY484 4.0 25.2 1.0 HD23 A:LEU535 4.0 37.8 1.0 H A:GLY484 4.0 30.2 1.0 CD2 A:LEU535 4.3 31.5 1.0 C A:PRO483 4.5 26.3 1.0 O A:ALA534 4.6 35.1 1.0 HB3 A:PRO483 4.7 33.0 1.0 CA A:LEU535 4.7 31.4 1.0 HB2 A:PRO483 4.7 33.0 1.0 O A:LEU535 4.8 32.7 1.0 HB3 A:LEU535 4.8 38.4 1.0 HD21 A:LEU535 4.9 37.8 1.0 O A:PRO483 4.9 26.7 1.0

O.J.Harrison, J.Brasch, P.S.Katsamba, G.Ahlsen, A.J.Noble, H.Dan, R.V.Sampogna, C.S.Potter, B.Carragher, B.Honig, L.Shapiro. Family-Wide Structural and Biophysical Analysis of Binding Interactions Among Non-Clustered Delta-Protocadherins. Cell Rep V. 30 2655 2020.
ISSN: ESSN 2211-1247
PubMed: 32101743
DOI: 10.1016/J.CELREP.2020.02.003